Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Oragenics, Inc. on February 17, 2025. The report addresses a change in the schedule for the Company's 2024 Annual Meeting of Shareholders and the resulting implications for shareholder proposal deadlines.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
- Annual Meeting Reschedule: The Board of Directors advanced the 2024 Annual Meeting of Shareholders to May 16, 2025.
- Regulatory Trigger: The new date is more than 30 days prior to the anniversary of the 2023 Annual Meeting, triggering a requirement under Rule 14a-5(f) to notify shareholders.
- Proposal Deadline: A new deadline for shareholder proposals under Rule 14a-8 has been set for March 14, 2025.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The document focuses solely on corporate governance procedures regarding the shareholder meeting.
Key Facts for Investor Verification
- Verify the final record date, time, and location for the 2024 Annual Meeting once the proxy statement is released.
- Note the March 14, 2025 deadline for submitting shareholder proposals intended for inclusion in the proxy statement.
- Confirm the submission address for proposals: Oragenics, Inc., Attn: Corporate Secretary, 1990 Main Street, Suite 750, Sarasota, Florida 34236.